Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
7Customers
2Debt Items
7Related Chains
Source-Backed Evidence Depth
Medifast, Inc. (MED) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
2Distinct source URLs
5High confidence
0.743Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from APT graph: Reciprocal relationship from MED graph: Reciprocal relationship from APT graph: Reciprocal relationship from MED graph: Reciprocal relationship from APT graph:…
Medifast, Inc. Customers
Ticker
Name
Confidence
Evidence
LIFEMD
LIFEMD
90%
Through the company’s collaboration with national virtual primary care provider LifeMD® and its affiliated medical group, customers now have access to GLP-1 medications where clinically appropriate.
FORECAST-MARKETDATA-LLC
FORECAST-MARKETDATA-LLC
62%
. We offer customers an approach to health that is designed for real life, with weight loss and weight management serving as a catalyst for an overall improvement in health, confidence, vitality and …
JASON-PHARMACEUTICALS-INC
JASON-PHARMACEUTICALS-INC
62%
ect to the state of direct selling and anti-pyramid laws and regulations. In the United States, for example, federal law provides the Federal Trade Commission (the “FTC”), broad latitude in policing …
JASON-PROPERTIES-LLC
JASON-PROPERTIES-LLC
62%
ket and drive sustainable growth. Our operations are conducted through our wholly owned subsidiaries, Jason Pharmaceuticals, Inc., OPTA VIA LLC, Jason Enterprises, Inc., Jason Properties, LLC, OPTA V…
MANUFACTURING-JASON-PHARMACEUTICALS-INC
MANUFACTURING-JASON-PHARMACEUTICALS-INC
62%
marketing efforts and serve as important advocates of our plans and products. We have a history of launching new products and plans to our coach network first to ensure that we have support from the …
OVERVIEW-MEDIFAST-INC
OVERVIEW-MEDIFAST-INC
62%
to allocate resources based on net income (loss) that also is reported on the accompanying Unaudited Condensed Consolidated Statements of Operations as net income (loss). The measure of segment asset…
STUDY-GROUP
STUDY-GROUP
62%
lding, et al; STEP 1 Study Group. Diabetes Obes Metab. 2022; https://pubmed.ncbi.nlm.nih.gov/35441470/ 4 O’Hearn M et al. Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018…
Medifast, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MED-DEBT
Debt stack $16.1M
90%
Market cache reports total debt of $16.1M.
MED-DEBT-10927
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2009-12-31.
Medifast, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Medifast, Inc..
Medifast, Inc. Ownership
Holder
Name
Confidence
Evidence
MED-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 117 tracked holders.
